Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Influenza A Virus Infection Induces Viral and Cellular Defective Ribosomal Products Encoded by Alternative Reading Frames.

Zanker DJ, Oveissi S, Tscharke DC, Duan M, Wan S, Zhang X, Xiao K, Mifsud NA, Gibbs J, Izzard L, Dlugolenski D, Faou P, Laurie KL, Vigneron N, Barr IG, Stambas J, Van den Eynde BJ, Bennink JR, Yewdell JW, Chen W.

J Immunol. 2019 May 15. pii: ji1900070. doi: 10.4049/jimmunol.1900070. [Epub ahead of print]

PMID:
31092636
2.

Cytosolic Processing Governs TAP-Independent Presentation of a Critical Melanoma Antigen.

Vigneron N, Ferrari V, Van den Eynde BJ, Cresswell P, Leonhardt RM.

J Immunol. 2018 Oct 1;201(7):1875-1888. doi: 10.4049/jimmunol.1701479. Epub 2018 Aug 22.

PMID:
30135181
3.

Production of spliced peptides by the proteasome.

Vigneron N, Stroobant V, Ferrari V, Abi Habib J, Van den Eynde BJ.

Mol Immunol. 2018 Apr 9. pii: S0161-5890(18)30109-3. doi: 10.1016/j.molimm.2018.03.030. [Epub ahead of print]

PMID:
29650230
4.

What have we learnt from studying the evolution of the arbuscular mycorrhizal symbiosis?

Vigneron N, Radhakrishnan GV, Delaux PM.

Curr Opin Plant Biol. 2018 Aug;44:49-56. doi: 10.1016/j.pbi.2018.02.004. Epub 2018 Mar 3. Review.

PMID:
29510317
5.

Peptide splicing by the proteasome.

Vigneron N, Ferrari V, Stroobant V, Abi Habib J, Van den Eynde BJ.

J Biol Chem. 2017 Dec 22;292(51):21170-21179. doi: 10.1074/jbc.R117.807560. Epub 2017 Nov 6. Review.

6.

Learning from the Proteasome How To Fine-Tune Cancer Immunotherapy.

Vigneron N, Abi Habib J, Van den Eynde BJ.

Trends Cancer. 2017 Oct;3(10):726-741. doi: 10.1016/j.trecan.2017.07.007. Epub 2017 Aug 24. Review.

PMID:
28958390
7.

Atelocollagen-mediated in vivo siRNA transfection in ovarian carcinoma is influenced by tumor site, siRNA target and administration route.

Meryet-Figuière M, Lecerf C, Varin E, Coll JL, Louis MH, Dutoit S, Giffard F, Blanc-Fournier C, Hedir S, Vigneron N, Brotin E, Pelletier L, Josserand V, Denoyelle C, Poulain L.

Oncol Rep. 2017 Oct;38(4):1949-1958. doi: 10.3892/or.2017.5882. Epub 2017 Aug 4.

8.

Towards a new standardized method for circulating miRNAs profiling in clinical studies: Interest of the exogenous normalization to improve miRNA signature accuracy.

Vigneron N, Meryet-Figuière M, Guttin A, Issartel JP, Lambert B, Briand M, Louis MH, Vernon M, Lebailly P, Lecluse Y, Joly F, Krieger S, Lheureux S, Clarisse B, Leconte A, Gauduchon P, Poulain L, Denoyelle C.

Mol Oncol. 2016 Aug;10(7):981-92. doi: 10.1016/j.molonc.2016.03.005. Epub 2016 Apr 2.

9.

Proteasomes generate spliced epitopes by two different mechanisms and as efficiently as non-spliced epitopes.

Ebstein F, Textoris-Taube K, Keller C, Golnik R, Vigneron N, Van den Eynde BJ, Schuler-Thurner B, Schadendorf D, Lorenz FK, Uckert W, Urban S, Lehmann A, Albrecht-Koepke N, Janek K, Henklein P, Niewienda A, Kloetzel PM, Mishto M.

Sci Rep. 2016 Apr 6;6:24032. doi: 10.1038/srep24032.

10.

An overview of long non-coding RNAs in ovarian cancers.

Meryet-Figuière M, Lambert B, Gauduchon P, Vigneron N, Brotin E, Poulain L, Denoyelle C.

Oncotarget. 2016 Jul 12;7(28):44719-44734. doi: 10.18632/oncotarget.8089. Review.

11.

Long-Peptide Cross-Presentation by Human Dendritic Cells Occurs in Vacuoles by Peptide Exchange on Nascent MHC Class I Molecules.

Ma W, Zhang Y, Vigneron N, Stroobant V, Thielemans K, van der Bruggen P, Van den Eynde BJ.

J Immunol. 2016 Feb 15;196(4):1711-20. doi: 10.4049/jimmunol.1501574. Epub 2016 Jan 20.

12.

The capture proteasome assay (CAPA) to evaluate subtype-specific proteasome inhibitors.

Vigneron N, Abi Habib J, Van den Eynde BJ.

Data Brief. 2015 May 18;4:146-51. doi: 10.1016/j.dib.2015.04.019. eCollection 2015 Sep.

13.

Human Tumor Antigens and Cancer Immunotherapy.

Vigneron N.

Biomed Res Int. 2015;2015:948501. doi: 10.1155/2015/948501. Epub 2015 Jun 16. Review.

14.

Expression profile of the human IDO1 protein, a cancer drug target involved in tumoral immune resistance.

Vigneron N, van Baren N, Van den Eynde BJ.

Oncoimmunology. 2015 Feb 3;4(5):e1003012. eCollection 2015 May.

15.

The capture proteasome assay: A method to measure proteasome activity in vitro.

Vigneron N, Abi Habib J, Van den Eynde BJ.

Anal Biochem. 2015 Aug 1;482:7-15. doi: 10.1016/j.ab.2015.04.019. Epub 2015 Apr 23.

PMID:
25912419
16.

Deciphering preferential interactions within supramolecular protein complexes: the proteasome case.

Fabre B, Lambour T, Garrigues L, Amalric F, Vigneron N, Menneteau T, Stella A, Monsarrat B, Van den Eynde B, Burlet-Schiltz O, Bousquet-Dubouch MP.

Mol Syst Biol. 2015 Jan 5;11(1):771. doi: 10.15252/msb.20145497.

17.

Proteasome subtypes and regulators in the processing of antigenic peptides presented by class I molecules of the major histocompatibility complex.

Vigneron N, Van den Eynde BJ.

Biomolecules. 2014 Nov 18;4(4):994-1025. doi: 10.3390/biom4040994. Review.

18.

miR-491-5p-induced apoptosis in ovarian carcinoma depends on the direct inhibition of both BCL-XL and EGFR leading to BIM activation.

Denoyelle C, Lambert B, Meryet-Figuière M, Vigneron N, Brotin E, Lecerf C, Abeilard E, Giffard F, Louis MH, Gauduchon P, Juin P, Poulain L.

Cell Death Dis. 2014 Oct 9;5:e1445. doi: 10.1038/cddis.2014.389.

19.

A spliced antigenic peptide comprising a single spliced amino acid is produced in the proteasome by reverse splicing of a longer peptide fragment followed by trimming.

Michaux A, Larrieu P, Stroobant V, Fonteneau JF, Jotereau F, Van den Eynde BJ, Moreau-Aubry A, Vigneron N.

J Immunol. 2014 Feb 15;192(4):1962-71. doi: 10.4049/jimmunol.1302032. Epub 2014 Jan 22.

20.

Database of T cell-defined human tumor antigens: the 2013 update.

Vigneron N, Stroobant V, Van den Eynde BJ, van der Bruggen P.

Cancer Immun. 2013 Jul 15;13:15. Print 2013. Review.

21.

Critical residues in the PMEL/Pmel17 N-terminus direct the hierarchical assembly of melanosomal fibrils.

Leonhardt RM, Vigneron N, Hee JS, Graham M, Cresswell P.

Mol Biol Cell. 2013 Apr;24(7):964-81. doi: 10.1091/mbc.E12-10-0742. Epub 2013 Feb 6.

22.

Identifying source proteins for MHC class I-presented peptides.

Vigneron N, Ma W, Michaux A, Van den Eynde BJ.

Methods Mol Biol. 2013;960:187-207. doi: 10.1007/978-1-62703-218-6_16.

PMID:
23329489
23.

Inefficient exogenous loading of a tapasin-dependent peptide onto HLA-B*44:02 can be improved by acid treatment or fixation of target cells.

Stroobant V, Demotte N, Luiten RM, Leonhardt RM, Cresswell P, Bonehill A, Michaux A, Ma W, Mulder A, Van den Eynde BJ, van der Bruggen P, Vigneron N.

Eur J Immunol. 2012 Jun;42(6):1417-28. doi: 10.1002/eji.201141954.

24.

Proteasome subtypes and the processing of tumor antigens: increasing antigenic diversity.

Vigneron N, Van den Eynde BJ.

Curr Opin Immunol. 2012 Feb;24(1):84-91. doi: 10.1016/j.coi.2011.12.002. Epub 2011 Dec 27. Review.

PMID:
22206698
25.

An antigenic peptide produced by reverse splicing and double asparagine deamidation.

Dalet A, Robbins PF, Stroobant V, Vigneron N, Li YF, El-Gamil M, Hanada K, Yang JC, Rosenberg SA, Van den Eynde BJ.

Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):E323-31. doi: 10.1073/pnas.1101892108. Epub 2011 Jun 13.

26.

Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes.

Vigneron N, Van den Eynde BJ.

Cell Mol Life Sci. 2011 May;68(9):1503-20. doi: 10.1007/s00018-011-0658-x. Epub 2011 Mar 9. Review.

PMID:
21387143
27.

Proprotein convertases process Pmel17 during secretion.

Leonhardt RM, Vigneron N, Rahner C, Cresswell P.

J Biol Chem. 2011 Mar 18;286(11):9321-37. doi: 10.1074/jbc.M110.168088. Epub 2011 Jan 19.

28.

A MAGE-C2 antigenic peptide processed by the immunoproteasome is recognized by cytolytic T cells isolated from a melanoma patient after successful immunotherapy.

Ma W, Vigneron N, Chapiro J, Stroobant V, Germeau C, Boon T, Coulie PG, Van den Eynde BJ.

Int J Cancer. 2011 Nov 15;129(10):2427-34. doi: 10.1002/ijc.25911. Epub 2011 Apr 20.

29.

Differences in the production of spliced antigenic peptides by the standard proteasome and the immunoproteasome.

Dalet A, Stroobant V, Vigneron N, Van den Eynde BJ.

Eur J Immunol. 2011 Jan;41(1):39-46. doi: 10.1002/eji.201040750. Epub 2010 Dec 9.

30.

Endoplasmic reticulum export, subcellular distribution, and fibril formation by Pmel17 require an intact N-terminal domain junction.

Leonhardt RM, Vigneron N, Rahner C, Van den Eynde BJ, Cresswell P.

J Biol Chem. 2010 May 21;285(21):16166-83. doi: 10.1074/jbc.M109.097725. Epub 2010 Mar 15.

31.

Splicing of distant peptide fragments occurs in the proteasome by transpeptidation and produces the spliced antigenic peptide derived from fibroblast growth factor-5.

Dalet A, Vigneron N, Stroobant V, Hanada K, Van den Eynde BJ.

J Immunol. 2010 Mar 15;184(6):3016-24. doi: 10.4049/jimmunol.0901277. Epub 2010 Feb 12.

32.

[Antigenic peptides for peptide splicing in the proteosome].

Vigneron N.

Bull Mem Acad R Med Belg. 2010;165(5-6):305-9. French.

PMID:
21513118
33.

Functional significance of tapasin membrane association and disulfide linkage to ERp57 in MHC class I presentation.

Vigneron N, Peaper DR, Leonhardt RM, Cresswell P.

Eur J Immunol. 2009 Sep;39(9):2371-6. doi: 10.1002/eji.200939536.

34.

Cognitive function and 99mTc-ECD brain SPECT are significantly correlated in patients with primary Sjogren syndrome: a case-control study.

Le Guern V, Belin C, Henegar C, Moroni C, Maillet D, Lacau C, Dumas JL, Vigneron N, Guillevin L.

Ann Rheum Dis. 2010 Jan;69(1):132-7. doi: 10.1136/ard.2008.090811.

PMID:
19158115
35.

Towards a new classification of the Arthoniales (Ascomycota) based on a three-gene phylogeny focussing on the genus Opegrapha.

Ertz D, Miadlikowska J, Lutzoni F, Dessein S, Raspé O, Vigneron N, Hofstetter V, Diederich P.

Mycol Res. 2009 Jan;113(Pt 1):141-52. doi: 10.1016/j.mycres.2008.09.002. Epub 2008 Sep 27.

PMID:
18929650
36.

C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients.

Tykodi SS, Fujii N, Vigneron N, Lu SM, Mito JK, Miranda MX, Chou J, Voong LN, Thompson JA, Sandmaier BM, Cresswell P, Van den Eynde B, Riddell SR, Warren EH.

Clin Cancer Res. 2008 Aug 15;14(16):5260-9. doi: 10.1158/1078-0432.CCR-08-0028.

37.

An antigen produced by splicing of noncontiguous peptides in the reverse order.

Warren EH, Vigneron NJ, Gavin MA, Coulie PG, Stroobant V, Dalet A, Tykodi SS, Xuereb SM, Mito JK, Riddell SR, Van den Eynde BJ.

Science. 2006 Sep 8;313(5792):1444-7.

38.

Natural layer-by-layer photonic structure in the squamae of Hoplia coerulea (Coleoptera).

Vigneron JP, Colomer JF, Vigneron N, Lousse V.

Phys Rev E Stat Nonlin Soft Matter Phys. 2005 Dec;72(6 Pt 1):061904. Epub 2005 Dec 12.

PMID:
16485971
39.

A peptide derived from melanocytic protein gp100 and presented by HLA-B35 is recognized by autologous cytolytic T lymphocytes on melanoma cells.

Vigneron N, Ooms A, Morel S, Ma W, Degiovanni G, Van den Eynde BJ.

Tissue Antigens. 2005 Feb;65(2):156-62.

PMID:
15713214
40.

High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens.

Germeau C, Ma W, Schiavetti F, Lurquin C, Henry E, Vigneron N, Brasseur F, Lethé B, De Plaen E, Velu T, Boon T, Coulie PG.

J Exp Med. 2005 Jan 17;201(2):241-8.

41.

An antigenic peptide produced by peptide splicing in the proteasome.

Vigneron N, Stroobant V, Chapiro J, Ooms A, Degiovanni G, Morel S, van der Bruggen P, Boon T, Van den Eynde BJ.

Science. 2004 Apr 23;304(5670):587-90. Epub 2004 Mar 4.

42.

Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2.

Ma W, Germeau C, Vigneron N, Maernoudt AS, Morel S, Boon T, Coulie PG, Van den Eynde BJ.

Int J Cancer. 2004 May 1;109(5):698-702.

43.

Identification of a new peptide recognized by autologous cytolytic T lymphocytes on a human melanoma.

Vigneron N, Ooms A, Morel S, Degiovanni G, Van Den Eynde BJ.

Cancer Immun. 2002 Jul 19;2:9.

44.

[Treatment of polycythemia. I--Using radiophosphorus with or without treatment in 483 patients over 65 years of age].

Najean Y, Rain JD, Goguel A, Grange MJ, Vigneron N, Dupuy E, Mougeot-Martin M.

Ann Med Interne (Paris). 1998 Mar;149(2):87-93. French.

PMID:
11490530
45.

Pregnancy after embolization of uterine myoma: report of 12 cases.

Ravina JH, Vigneron NC, Aymard A, Le Dref O, Merland JJ.

Fertil Steril. 2000 Jun;73(6):1241-3.

PMID:
10856491
46.

Somatostatin receptor imaging in small cell lung cancer.

Berenger N, Moretti JL, Boaziz C, Vigneron N, Morere JF, Breau JL.

Eur J Cancer. 1996 Jul;32A(8):1429-31.

PMID:
8869110
47.

Maternal factors associated with perinatal HIV-1 transmission: the French Cohort Study: 7 years of follow-up observation. The French Pediatric HIV Infection Study Group.

Mayaux MJ, Blanche S, Rouzioux C, Le Chenadec J, Chambrin V, Firtion G, Allemon MC, Vilmer E, Vigneron NC, Tricoire J, et al.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Feb 1;8(2):188-94.

PMID:
7834401
48.

"Luxury perfusion" with 99mTc-HMPAO and 123I-IMP SPECT imaging during the subacute phase of stroke.

Moretti JL, Defer G, Cinotti L, Cesaro P, Degos JD, Vigneron N, Ducassou D, Holman BL.

Eur J Nucl Med. 1990;16(1):17-22.

PMID:
2307169
49.

Temporal evolution of brain distribution of IMP and HIPDM. Concise communication.

Moretti JL, Kung HF, Cesaro P, Blau M, Defer G, Holman L, Vigneron N, Rapin JR.

Nucl Med Commun. 1987 Jul;8(7):597-602.

PMID:
3500438
50.

Amines for brain tomoscintigraphy.

Moretti JL, Cinotti L, Cesaro P, Defer G, Joulin Y, Sergent A, Vigneron N, Rapin JR, Raynaud C.

Nucl Med Commun. 1987 Jul;8(7):581-95.

PMID:
3500437

Supplemental Content

Loading ...
Support Center